Your weekly roundup of the latest news from Drug Topics®.
A recent study examined the effects that different work environments can have on adults with asthma.
Hesitation from patients and providers to switch to an infliximab biosimilar may not be necessary, new study finds.
According to Dermavant, tapinarof cream 1% is a novel, aryl hydrocarbon receptor agonist in development as a once-daily topical cream.
G2Retro, developed by investigators from Ohio State University, can produce hundreds of new reaction predictions in just a few minutes.